The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) represents health professionals and scientific societies related to respiratory disease in South Korea. KATRD endeavors to promote research, patient care, and education in the field of respiratory disease and to improve the health of patients with respiratory diseases in South Korea. Founded in 1953, KATRD has the 66 years of history. Since 1962, the society has held more than 120 academic conferences and 1,656 membership.
Strados Labs
Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Enabling remote monitoring of lung health, Strados Labs’ RESP Biosensor allows clinicians to continuously measure patients’ lung sounds such as cough and wheeze that can indicate an exacerbation or reduced quality of life. The technology is used to assist drug developers in demonstrating treatment efficacy in clinical trials and to support clinicians in disease surveillance and management. The RESP Biosensor is FDA-cleared, CE marked and HIPAA compliant, backed by multiple awards and clinical publications. Strados Labs is privately owned and based in Philadelphia, PA.
Shionogi
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., an over 145-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages our science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need. Shionogi strives constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve. | Shionogi, Inc. is a subsidiary of Shionogi & Co., Ltd., a 145-year-old global pharmaceutical company headquartered in Osaka, Japan. Shionogi Inc. leverages our science-based heritage to develop & commercialize pharmaceutical products to treat unmet medical needs in our core area of infectious diseases and other areas of high medical need. | Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a Japanese research-driven pharmaceutical company. Since 1878, we have been harnessing the full potential of science to address global health challenges. Over the past six decades, we have discovered several novel antibiotics and medications for HIV and influenza. Today, we’re building on our scientific legacy by providing an antibiotic for difficult-to-treat Gram-negative bacterial infections and developing an investigational oral antiviral for COVID-19. Beyond infectious
Praxis Medical LLC
Praxis Medical is committed to developing innovative technologies that address unmet clinical needs to improve the lives of doctors, providers, and most importantly, patients. We are developing EndoCore- the world’s first motorized EBUS fine needle biopsy device. The EndoCore is designed to rotate the EBUS needle at the time of biopsy to harvest more cellular material in fewer passes. *This device is investigational.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.
Northwestern Medicine Canning Thoracic Institute
Northwestern Medicine Canning Thoracic Institute is among the top-ranked for pulmonology and lung surgery.